Ureteral Reimplantation for Vesicoureteral Reflux (VUR)
Treatment for Urogenital congenital anomalies
Effectiveness
96%
Safety Score
65%
Clinical Trials
400
Participants
25K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate anatomical correction, reflux resolution confirmed post-op
Treatment Duration
Single surgery, follow-up for several years
Evidence Quality
HIGHNumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$3,500
Side Effect Mgmt:$1,000
Total Annual:$18,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$35,000/QALY
QALYs Gained
1.8
Outcome-Based Costs
Cost per Responder
$18,750
Cost per Remission
$18,750
Comparison vs Continuous Antibiotic Prophylaxis + Watchful Waiting
Cost Difference
$0/year
Same cost
QALY Difference
+1.80 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Ureteral Reimplantation for Vesicoureteral Reflux (VUR) Outcomes
for Urogenital congenital anomalies
Efficacy Outcomes
Overall Effectiveness
+96%
Response Rate
+96%
Remission Rate
+96%
Common Side Effects
Bladder spasm/pain
+20%
Urinary tract infection (post-op)
+8%
Temporary ureteral obstruction
+3%
Persistent VUR
+4%
Urinary retention
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov